SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-009944
Filing Date
2023-05-15
Accepted
2023-05-15 17:00:48
Documents
15
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20230515x8k.htm   iXBRL 8-K 34970
2 EX-99.1 pmn-20230515xex99d1.htm EX-99.1 127418
3 GRAPHIC pmn-20230515xex99d1001.jpg GRAPHIC 6463
  Complete submission text file 0001558370-23-009944.txt   315508

Data Files

Seq Description Document Type Size
4 EX-101.SCH pmn-20230515.xsd EX-101.SCH 3954
5 EX-101.DEF pmn-20230515_def.xml EX-101.DEF 2874
6 EX-101.LAB pmn-20230515_lab.xml EX-101.LAB 17909
7 EX-101.PRE pmn-20230515_pre.xml EX-101.PRE 11840
9 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20230515x8k_htm.xml XML 5044
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 23923942
SIC: 2834 Pharmaceutical Preparations